Profil
Emmanuel Caeymaex is currently Executive Vice President-Patient Evidence at UCB SA since 1994.
Former positions include Director at Dermira, Inc. in 2017 and President at UCB Japan Co. Ltd. from 2006 to 2011.
Education includes graduate degrees from Université Catholique de Louvain and CEMS.
The Global Alliance in Management Education.
Postes actifs de Emmanuel Caeymaex
| Sociétés | Poste | Début |
|---|---|---|
| UCB | Corporate Officer/Principal | 01/03/1994 |
Anciens postes connus de Emmanuel Caeymaex
| Sociétés | Poste | Fin |
|---|---|---|
| DERMIRA, INC. | Directeur/Membre du Conseil | 06/11/2017 |
UCB Japan Co. Ltd.
UCB Japan Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | President | 01/06/2011 |
Formation de Emmanuel Caeymaex
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
UCB SA
UCB SA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Université Catholique de Louvain
Université Catholique de Louvain Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCB Japan Co. Ltd.
UCB Japan Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Dermira, Inc.
Dermira, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to patients living with chronic skin conditions | Health Technology |
CEMS The Global Alliance in Management Education
CEMS The Global Alliance in Management Education Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















